TARDBP and amyotrophic lateral sclerosis: As TDP-43 pathology is highly prevalent in amyotrophic lateral sclerosis [167], these results suggest that Nrf2 signalling may be disrupted in this manner in the majority of amyotrophic lateral sclerosis cases.